NASDAQ: PACHPioneer Acquisition I Corp Stock
$10.26+0.00 (+0%)
Updated Jul 8, 2026
PACH Price
$10.26
Fair Value Price
N/A
Market Cap
$291.79M
52 Week Low
$9.94
52 Week High
$10.27
P/E
42.75x
P/B
-25.12x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.64M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.06
Operating Cash Flow
-$739k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PACH Overview
Pioneer Acquisition I Corp focuses on effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities in healthcare or healthcare related industries. The was incorporated in 2024 and is based in Brooklyn, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PACH's potential to beat the market
- PACH doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
PACH
RankedUnranked of 41
RankedUnranked of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.79 | C | |
| $11.82 | C | |
| $20.62 | C |
Be the first to know about important PACH news, forecast changes, insider trades & much more!
PACH News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PACH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PACH is poor value based on its earnings relative to its share price (42.75x), compared to the US market average (10.17x)
P/E vs Market Valuation
PACH is poor value based on its earnings relative to its share price (42.75x), compared to the US Shell Companies industry average (14.15x)
P/E vs Industry Valuation
PACH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PACH due diligence checks available for Premium users.
Valuation
PACH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.75x
Industry
14.15x
Market
10.17x
PACH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PACH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PACH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-25.12x
Industry
72.16x
PACH's financial health
Profit margin
Revenue
$0.0
Net Income
$2.0M
Profit Margin
0%
PACH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$261.3M
Liabilities
$12.3M
Debt to equity
-1.06
PACH's short-term assets ($654.34k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PACH's long-term liabilities ($12.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PACH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PACH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$196.2k
Investing
$0.0
Financing
$0.0
PACH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PACH vs Shell Company Stocks
Pioneer Acquisition I Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.